Curanex Pharmaceuticals Inc. (CURX)
NASDAQ:CURX
Total Valuation
Curanex Pharmaceuticals Inc. has a market cap or net worth of $13.34M. The enterprise value is $8.70M.
Market Cap$13.34M
Enterprise Value$8.70M
Share Statistics
Curanex Pharmaceuticals Inc. has 28,364,813 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,364,813
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Curanex Pharmaceuticals Inc.’s return on equity (ROE) is -0.38 and return on invested capital (ROIC) is -36.65%.
Return on Equity (ROE)-0.38
Return on Assets (ROA)-0.36
Return on Invested Capital (ROIC)-36.65%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Curanex Pharmaceuticals Inc. is ―. Curanex Pharmaceuticals Inc.’s PEG ratio is -0.00165.
PE Ratio―
PS Ratio0.00
PB Ratio0.75
Price to Fair Value0.75
Price to FCF-0.80
Price to Operating Cash Flow-1.14
PEG Ratio-0.00165
Income Statement
In the last 12 months, Curanex Pharmaceuticals Inc. had revenue of 0.00 and earned -4.23M in profits. Earnings per share was -0.17.
Revenue0.00
Gross Profit0.00
Operating Income-4.24M
Pretax Income-4.23M
Net Income-4.23M
EBITDA-4.24M
Earnings Per Share (EPS)-0.17
Cash Flow
In the last 12 months, operating cash flow was -10.48M and capital expenditures 0.00, giving a free cash flow of -10.48M billion.
Operating Cash Flow-10.48M
Free Cash Flow-10.48M
Free Cash Flow per Share-0.37
Dividends & Yields
Curanex Pharmaceuticals Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-88.31%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)36.88
Average Volume (3m)2.97M
Important Dates
Curanex Pharmaceuticals Inc. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Curanex Pharmaceuticals Inc. as a current ratio of 81.93, with Debt / Equity ratio of 3.09%
Current Ratio81.93
Quick Ratio81.93
Debt to Market Cap0.04
Net Debt to EBITDA1.09
Interest Coverage Ratio496.55
Taxes
In the past 12 months, Curanex Pharmaceuticals Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Curanex Pharmaceuticals Inc. EV to EBITDA ratio is -0.90, with an EV/FCF ratio of -0.36.
EV to Sales0.00
EV to EBITDA-0.90
EV to Free Cash Flow-0.36
EV to Operating Cash Flow-0.36
Balance Sheet
Curanex Pharmaceuticals Inc. has $4.97M in cash and marketable securities with $346.70K in debt, giving a net cash position of $4.63M billion.
Cash & Marketable Securities$4.97M
Total Debt$346.70K
Net Cash$4.63M
Net Cash Per Share$0.16
Tangible Book Value Per Share$0.44
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Curanex Pharmaceuticals Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―